Wikipedia -WSS

Wikipedia

author：leisure time 2025-08-28 08:39:58 - browse：2

Adam's take main illustration — Molly Ferguson/STAT

Annovis Bio had my biotech bull%^&! meter running red after it made a late change to the design of a Phase 3 study in Parkinson’s disease. But then I got an extraordinary explanation from CEO Maria Maccecchini. Now, I’m less worried about data spin because, by her own admission, the odds that the study succeeds, post endpoint change, are a lot lower.

Results from the completed Parkinson’s study, which is investigating Annovis’ drug called buntanetap, are well past due because of what the company has described as ongoing “data cleaning efforts.” The delay was announced on Jan. 24. Two weeks later, on Feb. 6, the primary efficacy endpoint of the study was changed, according to an update posted to the U.S. government’s clinical trials database.

Red flag, I thought, until I emailed Maccecchini, asking for an explanation. In response, she told me Annovis made the key endpoint change in August, based on a recommendation from officials at the Food and Drug Administration after the agency had reviewed data from an interim analysis of the study. It took the company another six months to update the study design in the ClinicalTrials.gov database, for reasons she did not explain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： 2 million sign

leisure time

WSS

Judge orders hearing on Trump's motion to disqualify Fulton County DA

Adidas to release second batch of Yeezy sneakers after breakup with Ye

House GOP plan to stem drug shortages differs from Democrats’

Adidas to release second batch of Yeezy sneakers after breakup with Ye

Japan raises alarm over China's military, Russia ties and Taiwan tensions in new defense paper

A pollution tax on older cars can be extended to London's suburbs after a British court ruling

explore

Wikipedia

focus

Medicare details structure of new drug price negotiation program

Doctors increasingly discourage vaping amid mounting health concerns

Trump demands the U.S. pay no more for drugs than other countries … again

Suspect in Ukraine detonates explosives at a courthouse, killing himself and wounding 2 officers

BioMarin wins approval for gene therapy to treat hemophilia A

Myanmar's Supreme Court hears arguments in 2 appeals by ousted leader Aung San Suu Kyi

At least 13 dead in Texas as scorching temps continue

HCA says smaller share of spending going to labor

Psychedelics group wrestles with new pharma identity

Sudan conflict brings new atrocities to Darfur as militias kill, rape, burn homes in rampages

leisure time

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

2 million sign

China demands US invite Hong Kong leader to economic meeting, adding to strains over crackdown

Biden's Plan B on student loan forgiveness relies on Higher Education Act: What to know

Young Chinese opt out of the rat race and pressures at home to pursue global nomad lifestyle

Supreme Court shows surprising restraint in chaotic year of crises: ANALYSIS

hotspot

leisure time

focus

Wikipedia